Purchase Order 75N93019P00711
Award Date
6/26/19
Potential Completion Date
9/30/19
Potential Value
$70K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a firm fixed-price purchase order contract worth $66,835.54 to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the custom synthesis of genes and antibodies to support NIAID's biomedical research and public health initiatives. The contract was awarded on a sole-source basis under the authority of FAR 13.106-1 due to Genscript being the...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $37,889.60 firm fixed-price purchase order contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for custom gene synthesis and expression services. This requirement was sole-sourced to Genscript due to their specialized expertise in producing the specific gene constructs needed to support NIAID's vaccine research and development efforts. The contract...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to GenScript USA Incorporated, a biotechnology company based in Piscataway, New Jersey. The $35,155.40 firm fixed-price purchase order did not have a set-aside designation. The contract supports GenScript's provision of specialized biological materials and services, including gene synthesis, protein production, and antibody...
This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
This federal contract award is for $17,568 to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The contract is for monoclonal antibodies and plasmids services to support biomedical research and public health initiatives. While the contract does not have a set-aside designation, Genscript has received other prime and...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,833.25 contract is for custom gene synthesis services to support NIAID's biomedical research and public health initiatives. While the award does not have a set-aside designation, Genscript has previously received some small business...